Rüdiger Weseloh
Fortune : 462 444 $ au 30/06/2026
Fortune : 462 444 $ au 30/06/2026
Rüdiger Weseloh currently works at Merck KGaA, as Senior Director-Business Development, EMD Serono, Inc., as Executive Director-Business Development, Nyrada, Inc., as Independent Non-Executive Director from 2019, and Merck Healthcare KGaA, as Senior Director-Global Business Development.
Dr. Weseloh also formerly worked at Gontard & Metallbank AG, as Equity Analyst, Oppenheim Research GmbH, as Analyst, bioXXmed AG, as Member-Supervisory Board, and Merck Serono GmbH, as Head-Business Development.
Dr. Weseloh received his graduate degree from the University of Bayreuth and doctorate degree from Center For Molecular Neurobiology Hamburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NYRADA, INC. 1,36% | 20/02/2026 | 1 483 332 ( 1,36% ) | 462 444 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NYRADA INC. | Directeur/Membre du Conseil | 01/06/2019 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2006 |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Corporate Officer/Principal | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Oppenheim Research GmbH
Oppenheim Research GmbH Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 03/07/2006 |
| GONTARD & METALLBANK AG | Corporate Officer/Principal | - |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Corporate Officer/Principal | - |
| BIOXXMED AG | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Gontard & Metallbank AG
Gontard & Metallbank AG Major BanksFinance Operates international commercial bank | Finance |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Bayreuth
University of Bayreuth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oppenheim Research GmbH
Oppenheim Research GmbH Investment Banks/BrokersFinance Provides brokerage services | Finance |
bioXXmed AG
bioXXmed AG Pharmaceuticals: MajorHealth Technology Manufactures active ingredients | Health Technology |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
Nyrada, Inc.
Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
Center For Molecular Neurobiology Hamburg
Center For Molecular Neurobiology Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national